The development of resistance to drugs used in the treatment of infectious diseases and cancers is becoming an increasing global health burden. Both therapeutic areas have had large quantities of money and man hours invested into tackling these problems in recent years, attracting attention and research from academia, industry, charities and governmental institutions with financial support being provided through both public and private organizations.
展开▼
